Retatrutide is a peptide that acts on three hormone receptors: GLP-1, GIP, and glucagon. This “triple-agonist" has potential powerful metabolic effects, helping regulate appetite, blood sugar, and energy use. In clinical trials, its shown stronger results in comparison to its counterparts, Semaglutide and Tirzepatide with up to 25% body weight reduction.

This product is for research only, not human consumption